83555-73-1

Usage

Uses

Used in Pharmaceutical Synthesis:
2-(4-Bromophenyl)morpholine is used as an intermediate in the synthesis of various pharmaceuticals for its potential biological and pharmacological activities. Its unique structure allows it to be a key component in the development of new drugs with specific therapeutic effects.
Used in Agrochemical Development:
In the agrochemical industry, 2-(4-Bromophenyl)morpholine is used as a building block in the creation of new compounds designed to protect crops and enhance agricultural productivity. Its potential antifungal and antimicrobial properties make it a promising candidate for use in pesticides and other agrochemical products.
Used in Organic Synthesis:
2-(4-Bromophenyl)morpholine is utilized as a versatile building block in organic synthesis, allowing chemists to create a wide range of heterocyclic compounds with diverse applications in various fields, including medicine, materials science, and chemical research.
Used in Medicinal Chemistry Research:
Due to its potential antifungal and antimicrobial properties, 2-(4-Bromophenyl)morpholine is used in medicinal chemistry research to explore its therapeutic potential and develop new treatments for various infections and diseases.
Used in Chemical Research:
2-(4-Bromophenyl)morpholine serves as a valuable compound in chemical research, where it is studied for its unique properties and potential applications in the development of new materials, catalysts, and other chemical products.

Upstream product

• 7644-04-4 4-bromophenacylamine 
• 1368418-27-2 6-(4-bromophenyl)morpholin-3-one 
• 1467061-25-1 N-(2-(4-bromophenyl)-2-hydroxyethyl)-2-chloroacetamide 
• 41147-82-4 4-Bromophenylethanolamine 
• 99-73-0 para-bromophenacyl bromide 
• 1131220-79-5 4-benzyl-2-(4-bromo-phenyl)-morpholine 

Downstream Products

• 1131220-82-0 tert-butyl 2-(4-bromophenyl)morpholine-4-carboxylate 
• 1312561-47-9 (RS)-5-trifluoromethyl-pyridine-2-carboxylic acid (4-morpholin-2-yl-phenyl)-amide hydrochloride 
• 1312565-84-6 (RS)-2-{4-[(5-trifluoromethyl-pyridine-2-carbonyl)-amino]-phenyl}-morpholine-4-carboxylic acid tert-butyl ester 
• 1131220-37-5 (S)-tert-butyl 2-(4-bromophenyl)morpholine-4-carboxylate 
• 920798-90-9 (S)-2-(4-bromo-phenyl)-morpholine 
• 920802-49-9 (R)-2-(4-bromophenyl)morpholine 
• 1312566-02-1 (R)-tert-butyl 2-(4-(diphenylmethyleneamino)phenyl)morpholine-4-carboxylate 
• 1312566-00-9 tert-butyl (2R)-2-(4-bromophenyl)morpholine-4-carboxylate 
• 1260220-42-5 (R)-tert-butyl 2-(4-aminophenyl)morpholine-4-carboxylate 
• 1312566-06-5 (S)-tert-butyl 2-(4-(diphenylmethyleneamino)phenyl)morpholine-4-carboxylate 
• 1260220-43-6 tert-butyl (2S)-2-(4-aminophenyl)morpholine-4-carboxylate 
• 1357267-39-0 (S)-1-(4-fluorobenzyl)-3-(4-(morpholin-2-yl)phenyl)urea hydrochloride 
• 1357267-37-8 (S)-tert-butyl 2-(4-(6-(2,2,2-trifluoroethoxy)nicotinamido)phenyl)morpholine-4-carboxylate 
• 1312564-19-4 (S)-N-(4-(morpholin-2-yl)phenyl)-6-(2,2,2-trifluoroethoxy)nicotinamide hydrochloride 

Relevant academic research and scientific papers

Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists

A new series of morpholine derivatives has been identified as selective DA D3 receptor antagonists; their in vitro profile and pharmacokinetic data are provided.

3-METHYL-2- ( (2S) -2- (4- (3-METHYL-L, 2, 4-0XADIAZ0L-5-YL) PHENYL) MORPHOLINO) -6- (PYRIMIDIN-4-YL) PYRIMIDIN-4 (3H) -ONE AS TAU PROTEIN KINASE INHIBITOR

A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g.